본문 바로가기
KERD
논문KCI 등재

A Randomized, Evaluator-Blinded, Split-Face Comparison Study of the Efficacy and Safety of a Novel Mannitol Containing Monophasic Hyaluronic Acid Dermal Filler for the Treatment of Moderate to Severe Nasolabial Folds

3

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류피부과학

초록

Background: Mannitol containing monophasic filler with higher crosslinking has not been well studied for moderate and severe nasolabial fold (NLF) correction. Objective: To compare the efficacy and safety of a novel mannitol containing hyaluronic acid (HA) filler (HA-G) with biphasic HA filler (HA-P) for moderate and severe NLF correction. Methods: Thirteen subjects with symmetric moderate to severe NLF received HA-G (in one NLF) and HA-P (in other NLF) and were evaluated for 24 weeks. Results: At both 12 and 24 weeks, the mean improvement in Genzyme 6-point grading scale from baseline was significantly greater in the side of face that was treated with HA-G than HA-P (1.96±0.91 vs. 1.54±0.73 at week 12; p=0.044, 1.88±0.78 vs. 1.3±0.79 at week 24; p=0.027, respectively). At 12 weeks, the mean Global Aesthetic Improvement Scale score was 2.92±0.93 for HA-G and 2.31±0.95 for HA-P (p=0.008). Both fillers were well tolerated. Conclusion: The HA filler HA-G provides better efficacy and similar local tolerability compared with HA-P in 6 months following treatment for moderate and severe NLF.

Abstract

Background: Mannitol containing monophasic filler with higher crosslinking has not been well studied for moderate and severe nasolabial fold (NLF) correction. Objective: To compare the efficacy and safety of a novel mannitol containing hyaluronic acid (HA) filler (HA-G) with biphasic HA filler (HA-P) for moderate and severe NLF correction. Methods: Thirteen subjects with symmetric moderate to severe NLF received HA-G (in one NLF) and HA-P (in other NLF) and were evaluated for 24 weeks. Results: At both 12 and 24 weeks, the mean improvement in Genzyme 6-point grading scale from baseline was significantly greater in the side of face that was treated with HA-G than HA-P (1.96±0.91 vs. 1.54±0.73 at week 12; p=0.044, 1.88±0.78 vs. 1.3±0.79 at week 24; p=0.027, respectively). At 12 weeks, the mean Global Aesthetic Improvement Scale score was 2.92±0.93 for HA-G and 2.31±0.95 for HA-P (p=0.008). Both fillers were well tolerated. Conclusion: The HA filler HA-G provides better efficacy and similar local tolerability compared with HA-P in 6 months following treatment for moderate and severe NLF.

참고문헌 (22)

  1. 김혁, "The Efficacy, Longevity, and Safety of Combined Radiofrequency Treatment and Hyaluronic Acid Filler for Skin Rejuvenation", Annals of Dermatology, 26(4), pp.447~456 (2014), 대한피부과학회
  2. Gold M, "The science and art of hyaluronic acid dermal filler use in esthetic applications", J Cosmet Dermatol, 8, pp.301~307 (2009)
  3. Andre P, "Hyaluronic acid and its use as a"rejuvenation"agent in cosmetic dermatology", Semin Cutan Med Surg, 23, pp.218~222 (2004)
  4. Carruthers A., "Non-animal-based hyaluronic acid fillers: scientific and technical considerations", Plast Reconstr Surg, 120, pp.33S~40S (2007)
  5. Wang F., "In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin", Arch Dermatol, 143, pp.155~163 (2007)
  6. Ohrem HL., "Why is mannitol becoming more and more popular as a pharmaceutical excipient in solid dosage forms?", Pharm Dev Technol, 19, pp.257~262 (2014)
  7. Andrews RJ., "Effects of mannitol on cerebral blood flow, blood pressure, blood viscosity, hematocrit, sodium, and potassium", Surg Neurol, 39, pp.218~222 (1993)
  8. Goodman GJ., "A comparison of the efficacy, safety, and longevity of two different hyaluronic acid dermal fillers in the treatment of severe nasolabial folds : a multicenter, prospective, randomized, controlled, single-blind, within-subject study", Clin Cosmet Investig Dermatol, 4, pp.197~205 (2011)
  9. Ascher B., "Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of severe nasolabial lines-6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study", J Cosmet Dermatol, 10, pp.94~98 (2011)
  10. Nast A., "Efficacy and durability of two hyaluronic acid-based fillers in the correction of nasolabial folds : results of a prospective, randomized, double-blind, actively controlled clinical pilot study", Dermatol Surg, 37, pp.768~775 (2011)
  11. Monheit GD., "Development and validation of a 6-point grading scale in patients undergoing correction of nasolabial folds with a collagen implant", Dermatol Surg, 36(Suppl 3), pp.1809~1816 (2010)
  12. Edsman K., "Gel properties of hyaluronic acid dermal fillers", Dermatol Surg, 38, pp.1170~1179 (2012)
  13. Falcone SJ., "Crosslinked hyaluronic acid dermal fillers : a comparison of rheological properties", J Biomed Mater Res A, 87, pp.264~271 (2008)
  14. Kablik J., "Comparative physical properties of hyaluronic acid dermal fillers", Dermatol Surg, 35(Suppl 1), pp.302~312 (2009)
  15. England MD., "Influence of antioxidants (mannitol and allopurinol) on oxygen free radical generation during and after cardiopulmonary bypass", Circulation, 74, pp.III134~III137 (1986)
  16. Weinbroum AA, "Mannitol prevents acute lung injury after pancreas ischemia-reperfusion : a dose-response, ex vivo study", Lung, 187, pp.215~224 (2009)
  17. Liu JH., "Baicalein significantly protects human retinal pigment epithelium cells against H2O2-induced oxidative stress by scavenging reactive oxygen species and downregulating the expression of matrix metalloproteinase-9 and vascular endothelial growth factor", J Ocul Pharmacol Ther, 26, pp.421~429 (2010)
  18. Khoury W., "Mannitol attenuates kidney damage induced by xanthine oxidase-associated pancreas ischemia-reperfusion", J Surg Res, 160, pp.163~168 (2010)
  19. Belda JI., "Hyaluronic acid combined with mannitol to improve protection against free-radical endothelial damage : experimental model", J Cataract Refract Surg, 31, pp.1213~1218 (2005)
  20. Baspeyras M., "Clinical and biometrological efficacy of a hyaluronic acid-based mesotherapy product : a randomised controlled study", Arch Dermatol Res, 305, pp.673~682 (2013)
  21. Taieb M., "Hyaluronic acid plus mannitol treatment for improved skin hydration and elasticity", J Cosmet Dermatol, 11, pp.87~92 (2012)
  22. Lemperle G., "A classification of facial wrinkles", Plast Reconstr Surg, 108, pp.1735~1750 (2001)

관련 논문AI추천

The Efficacy, Longevity, and Safety of Combined Radiofrequency Treatment and Hyaluronic Acid Filler for Skin Rejuvenation김혁, 고현주, 김범준, 박귀영, 박선영, 박원석, 배일홍, 최선영대한피부과학회 · Annals of Dermatology2014 · 제26권 제4호Investigation of the Degradation-Retarding Effect Caused by the Low Swelling Capacity of a Novel Hyaluronic Acid Filler Developed by Solid-Phase Crosslinking Technology고현주, 김범준, 박귀영, 박선영, 박원석, 아영찬, 여인권, 조성연대한피부과학회 · Annals of Dermatology2014 · 제26권 제3호A Double-Blind, Split-Face, Randomized Study on the Effects and Safety of Intradermal Injection of Botulinum Toxin A (Incobotulinum Toxin A) in the Cheek노형래, 박지혜, 신동민, 오세진, 이종은, 이종희, 장동휘대한피부과학회 · Annals of Dermatology2022 · 제34권 제6호Efficacy and Safety of Novel Botulinum Toxin Type A (Protoxin) in the Treatment of Moderate to Severe Glabellar Lines: A Multicenter, Randomized, Double-Blind, Active-Controlled Phase III Study석준, 신민경, Choi Sun Young, Han Hye Sung, Kim Beom Joon, Kim Moon Bum, Lee Jong Hun, Lee Yang Won, Son Hyung Seok, Yoo Kwang Ho대한피부과학회 · Annals of Dermatology2026 · 제38권 제1호A Double-Blind, Split-Face, Randomized Study on the Effects and Safety of Intradermal Injection of Botulinum Toxin A (Incobotulinum toxin A) in the Cheek노형래, 박지혜, 신동민, 오세진, 이종은, 이종희, 장동휘대한피부과학회 · Annals of Dermatology2023 · 제35권 제1호Efficacy and Safety of Hyaluronic Acid with and without Radiofrequency for Forehead Augmentation: A Pilot Study Using Three-Dimensional Imaging Analysis김혁, 김범준, 문석균, 박원석, 현무열대한피부과학회 · Annals of Dermatology2016 · 제28권 제1호

이 간행물의 다른 논문 (28건)